Indian Markets in Time Correction Phase; Defence, Cement Show Promise While IT Faces AI Challenges

1 min read     Updated on 11 Sept 2025, 07:41 PM
scanx
Reviewed by
Naman SharmaScanX News Team
whatsapptwittershare
Overview

Indian equity markets are experiencing range-bound trading due to high valuations and muted earnings growth. Jyotivardhan Jaipuria of Valentis Advisors identifies this as a 'time correction' phase. The cement sector shows promise due to consolidation and rising utilization rates. The defence sector presents a structural growth opportunity, supported by government initiatives. The IT sector faces challenges from U.S. economic conditions and potential AI-driven changes. Future market rallies are expected to be driven by earnings growth rather than valuation re-rating.

19145526

*this image is generated using AI for illustrative purposes only.

Indian equity markets are currently navigating a period of range-bound trading as investors grapple with high valuations, global uncertainties, and muted earnings growth. Jyotivardhan Jaipuria, Founder & MD of Valentis Advisors, characterizes the current market condition as a 'time correction' phase, following the sharp rally witnessed after the Covid-19 pandemic.

Macroeconomic Strength vs. Earnings Growth

While India's macroeconomic fundamentals remain robust, Jaipuria points out that corporate earnings growth has decelerated. He emphasizes that valuation expansion alone cannot sustain market growth without corresponding earnings improvements. This observation underscores the importance of earnings growth as a key driver for future market rallies.

Sector-Specific Outlook

Cement Sector: Potential Outperformer

The cement sector emerges as a potential bright spot in the current market landscape. Jaipuria highlights two key factors supporting this outlook:

  • Sector consolidation over the past 18 months
  • Rising utilization rates

These developments are expected to restore pricing power within the cement industry, potentially leading to improved performance.

Defence: A Structural Growth Story

The defence sector is positioned as a structural growth opportunity, supported by:

  • Government's push for indigenisation
  • Strong order books

These factors make the defence sector an attractive proposition for long-term investors, according to Jaipuria.

IT Sector: Facing Headwinds

In contrast, the IT sector is confronting several challenges:

  • Unfavorable macroeconomic conditions in the United States
  • Growing anti-outsourcing sentiment
  • Potential structural changes driven by artificial intelligence (AI)

Jaipuria notes that AI advancements may lead to reduced manpower requirements in the IT industry, presenting a significant challenge for the sector.

Market Expectations and Concerns

Investors are keenly awaiting the upcoming Federal Reserve meeting, with widespread expectations of a 50 basis point rate cut. However, uncertainties surrounding tariffs continue to be a concern for market participants.

Looking Ahead

Jaipuria emphasizes that the next significant market rally will likely be driven by earnings growth rather than valuation re-rating. This perspective suggests that investors should focus on companies and sectors with strong earnings potential in the current economic environment.

As Indian equity markets navigate this 'time correction' phase, sectors like defence and cement appear well-positioned for potential outperformance. Meanwhile, the IT sector may face challenges as it adapts to technological shifts and global economic dynamics. Investors are advised to closely monitor earnings growth as a key indicator for future market movements.

like18
dislike

JPMorgan Strategist Advises Profit-Taking in Pharma, Sees Long-Term Potential in Defence Stocks

1 min read     Updated on 22 Aug 2025, 03:11 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
whatsapptwittershare
Overview

Rajiv Batra, JPMorgan's Head of Asia & Co-Head of Global Emerging Markets Equity Strategy, highlights growth and policy as top concerns for global investors in Indian markets. He recommends booking profits in pharma stocks due to US generic investigations and underwhelming earnings. JPMorgan maintains a positive stance on financials but advises monitoring the Jackson Hole Symposium for potential impacts. Batra suggests a structural buy approach for defence stocks, citing increased global budgets, potential foreign partnerships, and India's focus on national security as growth drivers for the next 5-10 years.

17401287

*this image is generated using AI for illustrative purposes only.

Rajiv Batra, JPMorgan's Head of Asia & Co-Head of Global Emerging Markets Equity Strategy, has outlined key investment themes for Indian markets, highlighting growth and policy as top concerns among global investors.

Growth and Policy Concerns

Batra noted that investors are seeking double-digit growth in both earnings and nominal GDP before showing renewed interest in India. This indicates a cautious approach from global investors, who are closely monitoring India's economic performance and policy landscape.

Pharma Sector: Time to Book Profits

The strategist recommended taking profits in pharmaceutical stocks, citing two main factors:

  1. Concerns stemming from US generic investigations under Section 232
  2. Underwhelming quarterly earnings performance

Batra pointed out that the pharma sector has delivered an impressive 40% outperformance over the past three years. However, it now faces headwinds, including the Revlimid patent expiry, which is expected to reduce earnings contribution from 13% to 1%.

Positive Stance on Financials

JPMorgan maintains a positive outlook on the financial sector. However, Batra advised monitoring the Jackson Hole Symposium for potential impacts on rate cuts, which could affect the sector's performance.

Defence Sector: A Structural Buy

Batra advocated for a structural buy approach to defence stocks, citing several supporting factors:

  1. Increased global defence budgets
  2. Potential foreign partnerships
  3. India's focus on national security

These factors, according to Batra, are likely to drive growth prospects in the defence sector over the next 5-10 years.

Market Implications

Batra's insights suggest a nuanced approach to the Indian market:

  • Pharma: Investors might consider reallocating funds from pharmaceutical stocks that have seen significant gains.
  • Financials: The sector remains attractive but requires careful monitoring of global monetary policy trends.
  • Defence: Long-term investors may find opportunities in defence stocks, given the sector's growth potential.

Investors are advised to conduct their own research and consider their individual risk tolerance before making investment decisions based on these recommendations.

like17
dislike
More News on
Explore Other Articles